Wu Minrong, Tang Qiying, Cai Songqi, Zhu Liuhong, Lin Chong, Guan Yingying, Rao Shengxiang, Zhou Jianjun
Department of Radiology, Zhongshan Hospital (Xiamen), Fudan University, 668 Jinhu Road, Huli District, Xiamen City 361015, Fujian Province, People's Republic of China.
Department of Radiology, Zhongshan Hospital, Fudan University, 180 Fenlin Road, Shanghai, Xuhui District, 200032, People's Republic of China.
Eur J Radiol. 2023 Feb;159:110670. doi: 10.1016/j.ejrad.2022.110670. Epub 2022 Dec 24.
Evaluation of the diagnostic performance and reproducibility of the Ovarian-Adnexal Reporting and Data System (O-RADS) Magnetic Resonance Imaging (MRI) risk stratification system based on enhanced non-dynamic contrast-enhanced (non-DCE) MRI in the diagnosis of adnexal masses.
Patients who underwent conventional pelvic enhanced non-DCE MRI examination within one month prior to surgery formed the study population. Two experienced radiologists independently evaluated the images and assigned a score according to the O-RADS MRI risk stratification system. One of the radiologists reviewed the images and reassigned the scores after three months. Intra- and inter-observer agreement was evaluated with the k coefficient value. The adnexal masses that attained scores between 1 and 3 were considered benign, while those with scores of 4 or 5 were considered malignant. Analyses were conducted to determine the sensitivity, specificity, positive and negative predictive values, and receiver operating characteristic (ROC) curve, which were then used for evaluating the diagnostic efficacy of the developed system based on enhanced non-DCE MRI scan. The reference standard was histology.
A total of 308 patients (mean age: 42.09 ± 12.42 years, age range: 20-84 years) were enrolled in the study. Among the 362 adnexal masses from the included patients, there were 320 benign masses and 42 malignant masses. In the case of three readers, there were no malignant tumors scored 1-2. The O-RADS MRI score ≥ 4 was associated with malignancy resulted in a good diagnostic efficacy with the areas under the curve (AUC) values of 0.918 (95 % CI, 0.864-0.972), 0.905 (95 % CI, 0.842-0.968), and 0.882 (95 % CI, 0.815-0.950), the sensitivity values of 90.5 % (95 % CI, 87.5-93.5 %), 85.7 % (95 % CI, 82.1-89.3 %), and 83.3 % (95 % CI, 79.5-87.2 %), and the specificity values of 93.1 % (95 % CI, 90.5-95.7 %), 95.3 % (95 % CI, 93.1-97.5 %), and 93.1 % (95 % CI, 90.5-95.7 %) obtained for the three readers, respectively. Excellent intra-observer agreement and inter-observer agreement were observed with the k values of 0.883 (95 % CI, 0.814-0.952) and 0.848 (95 % CI, 0.770-0.926), respectively.
The O-RADS MRI risk stratification system based on enhanced non-DCE MRI scans exhibited high accuracy and reproducibility in the prediction of adnexal masses malignancy. Enhanced non-DCE MRI scan may offer an alternative diagnostic tool when DCE is not possible.
基于增强型非动态对比增强(non-DCE)磁共振成像(MRI)的卵巢附件报告和数据系统(O-RADS)风险分层系统在附件包块诊断中的诊断性能及可重复性评估。
选取术前1个月内接受常规盆腔增强non-DCE MRI检查的患者作为研究对象。两名经验丰富的放射科医生独立评估图像,并根据O-RADS MRI风险分层系统进行评分。其中一名放射科医生在3个月后复查图像并重新评分。采用k系数值评估观察者内及观察者间的一致性。将评分为1至3分的附件包块视为良性,评分为4或5分的视为恶性。进行分析以确定敏感性、特异性、阳性和阴性预测值以及受试者工作特征(ROC)曲线,进而基于增强型non-DCE MRI扫描评估所开发系统的诊断效能。参考标准为组织学检查结果。
共纳入308例患者(平均年龄:42.09 ± 12.42岁,年龄范围:20 - 84岁)。纳入患者的362个附件包块中,有320个良性包块和42个恶性包块。在三位阅片者的情况中,没有评分为1 - 2分的恶性肿瘤。O-RADS MRI评分≥4与恶性肿瘤相关,三位阅片者获得的曲线下面积(AUC)值分别为0.918(95%CI,0.864 - 0.972)、0.905(95%CI,0.842 - 0.968)和0.882(95%CI,0.815 - 0.950),敏感性值分别为90.5%(95%CI,87.5 - 93.5%)、85.7%(95%CI,82.1 - 89.3%)和83.3%(95%CI,79.5 - 87.2%),特异性值分别为93.1%(95%CI,90.5 - 95.7%)、95.3%(95%CI,93.1 - 97.5%)和93.1%(95%CI,90.5 - 95.7%),显示出良好的诊断效能。观察者内一致性和观察者间一致性良好,k值分别为0.883(95%CI,0.814 - 0.952)和0.848(95%CI,0.770 - 0.926)。
基于增强型non-DCE MRI扫描的O-RADS MRI风险分层系统在预测附件包块恶性方面具有较高的准确性和可重复性。当无法进行动态对比增强(DCE)时,增强型non-DCE MRI扫描可能提供一种替代诊断工具。